<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02282501</url>
  </required_header>
  <id_info>
    <org_study_id>Odu-4</org_study_id>
    <nct_id>NCT02282501</nct_id>
  </id_info>
  <brief_title>Leptin and Ghrelin in ICU</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>özgür yağan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>T.C. ORDU ÜNİVERSİTESİ</source>
  <brief_summary>
    <textblock>
      Enteral alimentation is the preferred modality of support in critical patients who have&#xD;
      acceptable digestive function and are unable to eat orally, but the advantages of continuous&#xD;
      versus intermittent administration are surrounded by controversy.&#xD;
&#xD;
      This prospective, randomised study was designed to compare two enteral feeding methods with&#xD;
      respect to changes in levels of leptin and ghrelin in ICU.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2014</start_date>
  <completion_date type="Actual">February 2016</completion_date>
  <primary_completion_date type="Actual">October 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline in serum leptin concentration at three weeks in ICU</measure>
    <time_frame>first, 7th, 14th and 21th day</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in serum ghrelin concentration at three weeks in ICU</measure>
    <time_frame>first, 7th, 14th and 21th day in ICU</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Critically Ill</condition>
  <arm_group>
    <arm_group_label>intermittent feeding</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Bolus infusion - The total daily feeding period was also 4-6 times a day.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>continuous feeding</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Continuous infusion - The daily desired amount was offered continuously for 20 hours a day.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>enteral feeding by nasogastric tube.</intervention_name>
    <description>method of administration enteral feeding by nasogastric tube.</description>
    <arm_group_label>continuous feeding</arm_group_label>
    <arm_group_label>intermittent feeding</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  who were unable to ingest an oral diet&#xD;
&#xD;
          -  given decision on enteral feeding&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Carcinomatosis&#xD;
&#xD;
          -  irreversible coma&#xD;
&#xD;
          -  death or discharge before 14 days of observation&#xD;
&#xD;
          -  contraindication to enteral feeding&#xD;
&#xD;
          -  intolerance to the prescribed nutrients or infusion regimen&#xD;
&#xD;
          -  burn&#xD;
&#xD;
          -  multiple trauma&#xD;
&#xD;
          -  morbid obesity&#xD;
&#xD;
          -  end stage liver or renal or lung disease&#xD;
&#xD;
          -  severe sepsis or septic shock&#xD;
&#xD;
          -  patients with percutaneous endoscopic gastrostomy&#xD;
&#xD;
          -  immunosuppressive drug use&#xD;
&#xD;
          -  severe hemodynamic instability&#xD;
&#xD;
          -  massive blood transfusion&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Anesthesiology and Reanimation Dept. Ordu University Training and Research Hospital</name>
      <address>
        <city>Altınordu</city>
        <state>Ordu</state>
        <zip>52100</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>March 2016</verification_date>
  <study_first_submitted>October 30, 2014</study_first_submitted>
  <study_first_submitted_qc>November 3, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 4, 2014</study_first_posted>
  <last_update_submitted>March 28, 2016</last_update_submitted>
  <last_update_submitted_qc>March 28, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 29, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>T.C. ORDU ÜNİVERSİTESİ</investigator_affiliation>
    <investigator_full_name>özgür yağan</investigator_full_name>
    <investigator_title>MD, assistant professor</investigator_title>
  </responsible_party>
  <keyword>leptin levels</keyword>
  <keyword>ghrelin levels</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Critical Illness</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

